• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login

    • China Fertility Services Companies

    ID: MRFR/HC/5690-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    China has seen significant growth in the fertility services sector due to factors such as changing demographics, increased awareness, and advancements in reproductive technologies. Several companies in China offer a range of fertility services, including assisted reproductive technologies (ART), in vitro fertilization (IVF), and other related services. Please note that the information provided here is based on the status up to my last update, and there may have been further developments since then.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    China Fertility Services Market Research Report-Forecast to 2035 Infographic
    Summary Table of Contents Segmentation Infographic

    Top Industry Leaders in the China Fertility Services Market

    China Fertility Services Key CompaniesLatest China Fertility Services Companies Update



    • Jan 2023: For an undisclosed fee, Fujifilm acquired Shenandoah Biotechnology, enhancing its cell and gene therapy capacity. Shenandoah, located in Warminster, Pennsylvania, enhances Fujifilm's capacity to generate recombinant proteins, particularly cytokines and growth factors, utilized in gene and cell treatments. According to its website, Shenandoah has a new Tuttnauer autoclave sterilizer, a 16x16 ColdBox, new air handling and RODI water systems, and an improved cGMP facility with bio-command software. According to Fujifilm, "all members" of the Shenandoah team are welcome. In 2006, the privately held business was founded. With the simultaneous $800 million takeover of Irvine Scientific Sales of California and IS Japan in 2018, Fujifilm jumped heavily into the cell and gene therapy supply industry.




    • Nov 2023: The firm stated that Cook Medical has agreed to sell Cooper Cos. certain product lines related to otolaryngology and reproductive health. $300 million was paid for the acquisition. About 2.5 percent of Cook Medical's revenues comprise the items in the sale. Cooper Cos. will take over manufacturing over a two-year timeframe. The announcement was made by the Federal Trade Commission around three months prior, indicating that the firms had withdrawn their proposal to purchase Cook Medical Reproductive Health for $875 million. The FTC investigated the previous deal's potential for anti-competitive behavior. A portion of Cook Medical's portfolio of products for maternal-fetal medicine, as well as supplies for gynecological surgery, disposable devices, accessories, and Doppler monitor technologies, are included in the new agreement.


    List of China Fertility Services Key companies in the market

    • Merck KGaA

    • Cooper Surgical

    • Ferring Pharmaceuticals

    • Irvine Scientific Sales Company, Inc.

    • Cook Medical

    • Vitrolife